Okita, R., Shimizu, K., Nojima, Y., Saisho, S., & Nakata, M. (2021). Tofacitinib overcomes an IFNγ‐induced decrease in NK cell‐mediated cytotoxicity via the regulation of immune‐related molecules in LC‐2/ad. Thorac Cancer.
শিকাগো স্টাইলে সাইটেশনOkita, Riki, Katsuhiko Shimizu, Yuji Nojima, Shinsuke Saisho, এবং Masao Nakata. "Tofacitinib Overcomes an IFNγ‐induced Decrease in NK Cell‐mediated Cytotoxicity Via the Regulation of Immune‐related Molecules in LC‐2/ad." Thorac Cancer 2021.
এমএলএ সাইটেশনOkita, Riki, et al. "Tofacitinib Overcomes an IFNγ‐induced Decrease in NK Cell‐mediated Cytotoxicity Via the Regulation of Immune‐related Molecules in LC‐2/ad." Thorac Cancer 2021.
সতর্কবাণী: সাইটেশন সবসময় 100% নির্ভুল হতে পারে না.